These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 2055074)

  • 1. Nonlinear dobutamine pharmacokinetics in a pediatric population.
    Banner W; Vernon DD; Minton SD; Dean JM
    Crit Care Med; 1991 Jul; 19(7):871-3. PubMed ID: 2055074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dobutamine pharmacokinetics and pharmacodynamics in pediatric intensive care patients.
    Habib DM; Padbury JF; Anas NG; Perkin RM; Minegar C
    Crit Care Med; 1992 May; 20(5):601-8. PubMed ID: 1572184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dobutamine infusions in stable, critically ill children: pharmacokinetics and hemodynamic actions.
    Berg RA; Donnerstein RL; Padbury JF
    Crit Care Med; 1993 May; 21(5):678-86. PubMed ID: 8482088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of exogenous epinephrine in critically ill children.
    Fisher DG; Schwartz PH; Davis AL
    Crit Care Med; 1993 Jan; 21(1):111-7. PubMed ID: 8420716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variability in dobutamine pharmacokinetics in unstable critically ill surgical patients.
    Klem C; Dasta JF; Reilley TE; Flancbaum LJ
    Crit Care Med; 1994 Dec; 22(12):1926-32. PubMed ID: 7988128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sulfoconjugation and renal excretion contribute to the interpatient variation of exogenous catecholamine clearance in critically ill children.
    Berg RA; Padbury JF
    Crit Care Med; 1997 Jul; 25(7):1247-51. PubMed ID: 9233755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pharmacokinetics of dobutamine in pediatric intensive care unit patients.
    Schwartz PH; Eldadah MK; Newth CJ
    Drug Metab Dispos; 1991; 19(3):614-9. PubMed ID: 1680627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonlinear dopamine pharmacokinetics in pediatric patients.
    Banner W; Vernon DD; Dean JM; Swenson E
    J Pharmacol Exp Ther; 1989 Apr; 249(1):131-3. PubMed ID: 2709327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations in dopamine clearance and catechol-O-methyltransferase activity by dopamine infusions in children.
    Allen E; Pettigrew A; Frank D; Thompson S; Myers C; Yamashita T; Blumer JL
    Crit Care Med; 1997 Jan; 25(1):181-9. PubMed ID: 8989196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of dopamine in infants and children.
    Eldadah MK; Schwartz PH; Harrison R; Newth CJ
    Crit Care Med; 1991 Aug; 19(8):1008-11. PubMed ID: 1860323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the renal effects of low to high doses of dopamine and dobutamine in critically ill patients: a single-blind randomized study.
    Ichai C; Soubielle J; Carles M; Giunti C; Grimaud D
    Crit Care Med; 2000 Apr; 28(4):921-8. PubMed ID: 10809260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age-related amrinone pharmacokinetics in a pediatric population.
    Allen-Webb EM; Ross MP; Pappas JB; McGough EC; Banner W
    Crit Care Med; 1994 Jun; 22(6):1016-24. PubMed ID: 8205809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Difference between the measured and ordered dose of catecholamine infusions.
    Allen EM; Van Boerum DH; Olsen AF; Dean JM
    Ann Pharmacother; 1995 Nov; 29(11):1095-100. PubMed ID: 8573951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal support in critically ill patients: low-dose dopamine or low-dose dobutamine?
    Duke GJ; Briedis JH; Weaver RA
    Crit Care Med; 1994 Dec; 22(12):1919-25. PubMed ID: 7988127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of dopamine in critically ill newborn infants.
    Padbury JF; Agata Y; Baylen BG; Ludlow JK; Polk DH; Habib DM; Martinez AM
    J Pediatr; 1990 Sep; 117(3):472-6. PubMed ID: 2391608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dobutamine pharmacokinetics and cardiovascular responses in critically ill neonates.
    Martinez AM; Padbury JF; Thio S
    Pediatrics; 1992 Jan; 89(1):47-51. PubMed ID: 1728020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beneficial hemodynamic effects of prostaglandin E1 infusion in catecholamine-dependent heart failure: results of a prospective, randomized, controlled study.
    Pacher R; Globits S; Wutte M; Rödler S; Heinz G; Kreiner G; Radosztics S; Berger R; Presch I; Weber H
    Crit Care Med; 1994 Jul; 22(7):1084-90. PubMed ID: 8026195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemodynamic response to intentionally altered flow continuity of dobutamine and dopamine by an infusion pump in infants.
    Stowe CD; Storgion SA; Lee KR; Phelps SJ
    Pharmacotherapy; 1996; 16(6):1018-23. PubMed ID: 8947973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopamine and dobutamine in pediatric therapy.
    Bhatt-Mehta V; Nahata MC
    Pharmacotherapy; 1989; 9(5):303-14. PubMed ID: 2682552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of dopamine and dobutamine on liver oxygen supply-uptake relationship in the dog.
    Kinoshita G; Washizu M; Murata N; Kondo M; Matsukura Y; Washizu T; Motoyoshi S
    J Vet Med Sci; 1995 Apr; 57(2):287-91. PubMed ID: 7492648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.